Hose v. Chicago Northwestern Transportation Co.

70 F.3d 968
CourtCourt of Appeals for the Eighth Circuit
DecidedNovember 22, 1995
DocketNos. 94-3300, 94-3376
StatusPublished
Cited by104 cases

This text of 70 F.3d 968 (Hose v. Chicago Northwestern Transportation Co.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hose v. Chicago Northwestern Transportation Co., 70 F.3d 968 (8th Cir. 1995).

Opinion

LAY, Circuit Judge.

This appeal arises out of a $1,333,279.31 jury verdict for personal injuries in favor of Delmas R. Hose against the Chicago and North Western Transportation Company (“CNW”) under the Federal Employers’ Liability Act, 45 U.S.C. §§ 51-60 (“FELA”). Hose worked as a welder at CNW’s reclamation center in Council Bluffs, Iowa, from 1976 [972]*972to 1991. The reclamation process exposed Hose to substantial amounts of fumes and dust containing manganese, a toxin. Hose’s evidence shows that CNW did not provide adequate ventilation, warnings, monitoring, or safety training in relation to manganese hazards in the work place.

In April 1991, Hose reported that he was suffering memory loss and had fallen in the welding shop when his right leg gave out. CNW directed him to take sick leave and not to return to work until he obtained medical approval.

In April 1992, Hose filed suit in federal district court against CNW under FELA. Hose also sued Stoody Deloro Stellite, Inc., and Arcair Company, who designed, manufactured, and sold the welding equipment used by CNW, on state law counts. CNW filed cross-claims against Stoody and Arcair. Prior to trial, Hose settled with Stoody and Arcair, and CNW’s cross-claims against them were dismissed. A three-week trial was held in 1994. The jury found CNW negligent under FELA and returned a verdict in Hose’s favor. The jury apportioned Hose’s damages finding CNW was ninety percent at fault, and Hose was ten percent eontribu-torily at fault. At CNW’s request, the jury was instructed to evaluate the contributing fault of Stoody and Arcair and found no fault on their part. The district court, the Honorable Harold D. Vietor, rejected CNW’s motions for judgment as a matter of law and a new trial. This appeal followed.

On appeal, CNW challenges the admissibility of certain expert medical testimony, the sufficiency of the evidence of medical causation, the exclusion of evidence of Hose’s claims against Stoody and Arcair and their subsequent settlement, and certain jury instructions. Hose cross-appeals the jury’s finding of ten percent contributory negligence. We affirm.

MEDICAL TESTIMONY

In February 1992, after a series of medical examinations and varying diagnoses by different specialists, Hose was examined by Dr. Carol Angle, who was then director of clinical toxicology and professor of pediatrics at the University of Nebraska Medical Center. Dr. Angle made the diagnosis that Hose was suffering from manganese encephalopathy. In March 1992, Dr. Jan Golnick, a neurologist, concurred in Dr. Angle’s diagnosis and removed Hose from seizure medication prescribed by another physician. Various other examinations and treatments followed.

Manganese encephalopathy is a dementia, or difficulty in thinking, that usually results from chronic exposure to manganese, and is usually associated with reduced ability to control one’s movements. (Tran. 491) (testimony of Dr. Angle). CNW challenges the expert opinion evidence of Hose’s physicians under Daubert v. Merrell Dow Pharmaceuticals, Inc., — U.S. -, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993) (interpreting Fed.R.Evid. 702).1 Under Daubert, the trial court plays a “gatekeeping role” to “ensure that any and all scientific testimony or evidence admitted is not only relevant, but reliable.” Id. at -, -, 113 S.Ct. at 2798, 2795. Relevance means there must be “a valid scientific connection to the pertinent inquiry” in the ease. Id. at -, 113 S.Ct. at 2796. Reliability means the evidence must be based upon scientific knowledge, i.e., “grounded] in the methods and procedures of science,” and must represent “more than [a] subjective belief or [an] unsupported speculation.” Id. at -, 113 S.Ct. at 2795.2

We review a trial court’s decision on the admissibility of expert medical evidence for a clear abuse of discretion. Gier v. Educational Serv. Unit No. 16, 66 F.3d 940, 942 (8th Cir.1995). If the party opposing the [973]*973evidence does not properly object, however, we review for plain error. Owen v. Patton, 925 F.2d 1111, 1115 (8th Cir.1991). Finally, we will not reverse a jury verdict if an erroneous admission of expert evidence is harmless. McKnight v. Johnson Controls, Inc., 86 F.3d 1396, 1405 (8th Cir.1994).

Dr. Gupta

CNW first challenges Dr. Naresh Gupta’s deposition testimony based on a positron emission tomography (“PET”) scan of Hose’s brain. The PET scan was ordered by Dr. Golnick to aid his ability to make a diagnosis. Dr. Gupta testified that the PET scan ruled out alternative diagnoses of Hose’s injuries, such as alcoholism, a stroke, and Alzheimer’s disease, but was “consistent” with manganese encephalopathy.

CNW sought to exclude use of the PET scan in a motion in limine and timely objected to Dr. Gupta’s testimony.3 CNW argued the PET scan was not scientifically reliable for use in making a diagnosis of manganese encephalopathy and was not relevant for any other purpose. The district court, however, admitted Dr. Gupta’s testimony because it was relevant in terms of excluding other diagnoses of Hose’s injuries and was limited to showing consistency with, not diagnostic proof of, manganese encephalopathy. Dr. Gupta further testified to the limited scientific experience and literature about using PET scans in manganese cases.

We find the district court did not abuse its discretion by allowing Dr. Gupta’s testimony based on the PET scan. Dr. Gupta’s testimony clearly showed the limited use of the PET scan, but that use was nonetheless relevant. In determining the cause of a person’s injuries, it is relevant that other possible sources of his injuries, argued for by defense counsel, have been ruled out by his treating physicians. Indeed, ruling out alternative explanations for injuries is a valid medical method. See McCullock v. H.B. Fuller, Inc., 61 F.3d 1038, 1043-44 (2d Cir.1995). There is also no question that the PET scan is scientifically reliable for measuring brain function. The fact that Hose’s treating physician ordered the PET scan pri- or to the initiation of litigation is another important indication that this technique is scientifically valid. Cf. Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1317 (9th Cir.) (expert testimony based on “legitimate, preexisting research unrelated to the litigation provides the most persuasive basis” for ensuring scientific validity of expert testimony), cert. denied, — U.S. -, 116 S.Ct. 189, 133 L.Ed.2d 126 (1995).

Dr. Andrews

CNW next challenges Dr. Richard Andrews’s deposition testimony regarding the polysomnogram conducted under his supervision. A polysomnogram assesses whether a person has any sleep disorders. Like the PET scan, the polysomnogram was ordered by Hose’s attending physician, Dr. Golnick. Dr. Andrews testified that Hose has a sleep disorder consistent with an exposure to a toxic substance.

[974]

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
70 F.3d 968, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hose-v-chicago-northwestern-transportation-co-ca8-1995.